Epigral Limited (NSE:EPIGRAL)

India flag India · Delayed Price · Currency is INR
1,194.55
-24.40 (-2.00%)
Apr 29, 2026, 3:29 PM IST
-35.60%
Market Cap 52.59B
Revenue (ttm) 24.19B
Net Income (ttm) 3.38B
Shares Out 43.14M
EPS (ttm) 78.35
PE Ratio 15.56
Forward PE 17.56
Dividend 7.00 (0.57%)
Ex-Dividend Date n/a
Volume 35,641
Average Volume 86,278
Open 1,225.05
Previous Close 1,218.95
Day's Range 1,190.00 - 1,233.60
52-Week Range 807.00 - 2,114.00
Beta -0.24
RSI 67.23
Earnings Date Apr 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc... [Read more]

Industry Chemicals
Sector Materials
Founded 2007
Employees 1,072
Stock Exchange National Stock Exchange of India
Ticker Symbol EPIGRAL
Full Company Profile

Financial Performance

In fiscal year 2025, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.

Financial Statements

News

There is no news available yet.